the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Wall Street ends mostly lower as chipmakers ease

NEW YORK: The S&P 500 and Nasdaq edged lower on Wednesday (March 13) as investors took profits in chipmaker stocks, while they braced for producer price data and further clues on the inflation trend ahead of next week’s Federal Reserve (Fed) meeting.

The Dow Jones Industrial Average rose 37.83 points, or 0.1%, to 39,043.32. The S&P 500 lost 9.96 points, or 0.19%, at 5,165.31 and the Nasdaq Composite dropped 87.87 points, or 0.54%, to 16,177.77.

An index of semiconductors eased 2.5% after recent strong gains, but was up 17% for the year to date. Shares of Nvidia, which have led the recent rally fueled by optimism about artificial intelligence, fell 1.1%.

Investors are looking ahead to Nvidia’s global GTC developer conference on AI from March 18-21 and any AI-related announcements.

Intel shares fell 4.4%. Bloomberg reported that the Pentagon had pulled out of a plan to spend as much as $2.5 billion on a chip grant to the company.

February US producer price data due on Thursday could offer further insight into the inflation picture.

“The last reading actually helped to underscore the hotter inflation trend. So this is going to be important,” said Quincy Krosby, chief global strategist at LPL Financial in Charlotte, North Carolina.

While the US central bank is widely expected to leave interest rates unchanged when it meets next week, traders see a 65% chance of the first rate cut coming in June, the CME FedWatch Tool showed.

Tuesday’s slightly hotter-than-expected consumer price data failed to dampen hopes of rate cuts in the coming months.

Monthly US retail sales data also is due on Thursday.

Among other declining shares, Dollar Tree slumped 14.2% after the discount store chain said it would close nearly 1,000 stores and posted a net loss in the previous quarter, hurt by an over-$1 billion goodwill impairment charge.

McDonald’s shares fell 3.9% after its chief financial officer said international sales could fall sequentially in the current quarter. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings